EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Terpene-Containing Analogues of Glitazars as Potential Therapeutic Agents for Metabolic Syndrome

Mikhail E Blokhin, Sergey O Kuranov, Mikhail V Khvostov iD, Vladislav V Fomenko iD, Olga A Luzina iD, Natalia A Zhukova, Cham Elhajjar, Tatiana G Tolstikova, Nariman F Salakhutdinov

Current Issues in Molecular Biology · 08.03.2023 · 45 (3) · 2230-2247

DOI: 10.3390/cimb45030144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 08.03.2023. Verfasst von Mikhail E Blokhin und 8 weiteren Autor:innen. Beteiligte Einrichtung: N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, 630090 Novosibirsk, Russia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: state assignments to N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic syndrome is a complex of abnormalities involving impaired glucose and lipid metabolism, which needs effective pharmacotherapy. One way to reduce lipid and glucose levels associated with this pathology is the simultaneous activation of nuclear PPAR-alpha and gamma. For this purpose, we synthesized a number of potential agonists based on the pharmacophore fragment of glitazars with the inclusion of mono- or diterpenic moiety in the molecular structure. The study of their pharmacological activity in mice with obesity and type 2 diabetes mellitus (C57Bl/6Ay) revealed one substance that was capable of reducing the triglyceride levels in the liver and adipose tissue of mice by enhancing their catabolism and expressing a hypoglycemic effect connected with the sensitization of mice tissue to insulin. It has also been shown to have no toxic effects on the liver.

Schlagwörter

Stichwörter der Autor:innen

ITTOGTTglitazarsisopimaric acidmetabolic syndrometerpenic derivatives

Autor:innen und Institutionen

  • N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, 630090 Novosibirsk, Russia.

ORCID-Profile: Mikhail V Khvostov, Vladislav V Fomenko, Olga A Luzina

Förderung

  • state assignments to N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS
  • N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS

Zitieren

APA

Blokhin, M. E., Kuranov, S. O., Khvostov, M. V., Fomenko, V. V., Luzina, O. A., Zhukova, N. A., Elhajjar, C., Tolstikova, T. G., & Salakhutdinov, N. F. (2023). Terpene-Containing Analogues of Glitazars as Potential Therapeutic Agents for Metabolic Syndrome. Current Issues in Molecular Biology, 45(3), 2230-2247. https://doi.org/10.3390/cimb45030144

Vancouver

Blokhin ME, Kuranov SO, Khvostov MV, Fomenko VV, Luzina OA, Zhukova NA, et al. Terpene-Containing Analogues of Glitazars as Potential Therapeutic Agents for Metabolic Syndrome. Current Issues in Molecular Biology. 2023;45(3):2230-2247. doi:10.3390/cimb45030144

BibTeX
@article{Blokhin2023,
  author = {Blokhin, Mikhail E and Kuranov, Sergey O and Khvostov, Mikhail V and Fomenko, Vladislav V and Luzina, Olga A and Zhukova, Natalia A and Elhajjar, Cham and Tolstikova, Tatiana G and Salakhutdinov, Nariman F},
  title = {Terpene-Containing Analogues of Glitazars as Potential Therapeutic Agents for Metabolic Syndrome},
  journal = {Current Issues in Molecular Biology},
  year = {2023},
  volume = {45},
  number = {3},
  pages = {2230--2247},
  doi = {10.3390/cimb45030144}
}
Kostenlos starten →